| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Cassava Sciences Inc (NASDAQ: SAVA)
SAVA Technical Analysis
4
| As on 9th Jun 2023 SAVA STOCK Price closed @ 24.31 and we RECOMMEND Sell for LONG-TERM with Stoploss of 32.76 & Strong Sell for SHORT-TERM with Stoploss of 43.76 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SAVASTOCK Price
| Open | 24.63 | Change | Price | % |
| High | 24.64 | 1 Day | -0.17 | -0.69 |
| Low | 23.80 | 1 Week | 1.60 | 7.05 |
| Close | 24.31 | 1 Month | 1.64 | 7.23 |
| Volume | 609400 | 1 Year | -19.36 | -44.33 |
| 52 Week High 53.05 | 52 Week Low 16.33 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| SAVA Daily Charts |
SAVA Intraday Charts |
Whats New @ Bazaartrend |
SAVA Free Analysis |
|
|
SAVA Important Levels Intraday
| RESISTANCE | 25.93 |
| RESISTANCE | 25.41 |
| RESISTANCE | 25.09 |
| RESISTANCE | 24.77 |
| SUPPORT | 23.85 |
| SUPPORT | 23.53 |
| SUPPORT | 23.21 |
| SUPPORT | 22.69 |
SAVA Forecast April 2024
| 4th UP Forecast | 80.19 |
| 3rd UP Forecast | 62.27 |
| 2nd UP Forecast | 51.19 |
| 1st UP Forecast | 40.12 |
| 1st DOWN Forecast | 8.51 |
| 2nd DOWN Forecast | -2.57 |
| 3rd DOWN Forecast | -13.65 |
| 4th DOWN Forecast | -31.57 |
SAVA Weekly Forecast
| 4th UP Forecast | 38.86 |
| 3rd UP Forecast | 34.19 |
| 2nd UP Forecast | 31.31 |
| 1st UP Forecast | 28.42 |
| 1st DOWN Forecast | 20.20 |
| 2nd DOWN Forecast | 17.31 |
| 3rd DOWN Forecast | 14.43 |
| 4th DOWN Forecast | 9.76 |
SAVA Forecast2024
| 4th UP Forecast | 118.06 |
| 3rd UP Forecast | 87.99 |
| 2nd UP Forecast | 69.41 |
| 1st UP Forecast | 50.82 |
| 1st DOWN Forecast | -2.2 |
| 2nd DOWN Forecast | -20.79 |
| 3rd DOWN Forecast | -39.37 |
| 4th DOWN Forecast | -69.44 |
Cassava Sciences Inc ( NASDAQ USA Symbol : SAVA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SAVA Business Profile
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas. Address: 7801 North Capital of Texas Highway, Austin, TX, United States, 78731
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service